Immunization technologies: Time to consider new preventative solutions for respiratory syncytial virus infections
New technologies for the prevention of infectious diseases are emerging to address unmet medical needs, in particular, the use of long-acting monoclonal antibodies (mAb) to prevent Respiratory Syncytial Virus (RSV) lower respiratory tract disease in infants during their first RSV season. The lack of...
Saved in:
Main Authors: | Catherine Weil-Olivier (Author), David Salisbury (Author), José Antonio Navarro-Alonso (Author), Chryssoula Tzialla (Author), Yan Zhang (Author), Susanna Esposito (Author), Fabio Midulla (Author), Tobias Tenenbaum (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Respiratory Syncytial Virus: The Urgent Need for Innovative Preventive Strategies
by: Fabrizio Virgili, et al.
Published: (2024) -
Respiratory syncytial virus infection and the need for immunization in Korea
by: Hye Young Kim, et al.
Published: (2023) -
Chapter 5 Respiratory Syncytial Virus
by: Jha, Akhilesh
Published: (2016) -
Chapter 5 Respiratory Syncytial Virus
by: Jha, Akhilesh
Published: (2016) -
Human Respiratory Syncytial Virus Infection
Published: (2011)